tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
NewAmsterdam Pharma Reports Q2 2025 Financial Results
PremiumCompany AnnouncementsNewAmsterdam Pharma Reports Q2 2025 Financial Results
23d ago
Promising Developments and Strong Financial Position Support Buy Rating for NewAmsterdam Pharma
Premium
Ratings
Promising Developments and Strong Financial Position Support Buy Rating for NewAmsterdam Pharma
23d ago
Buy Rating for NewAmsterdam Pharma Driven by Promising Trial Developments and Strategic Advancements
Premium
Ratings
Buy Rating for NewAmsterdam Pharma Driven by Promising Trial Developments and Strategic Advancements
23d ago
NewAmsterdam Pharma’s Promising Phase 3 Alzheimer’s Trial Results
PremiumCompany AnnouncementsNewAmsterdam Pharma’s Promising Phase 3 Alzheimer’s Trial Results
1M ago
NewAmsterdam Pharma presents data from BROADWAY trial at AAIC
Premium
The Fly
NewAmsterdam Pharma presents data from BROADWAY trial at AAIC
1M ago
NewAmsterdam Pharma initiated with a Neutral at Goldman Sachs
Premium
The Fly
NewAmsterdam Pharma initiated with a Neutral at Goldman Sachs
1M ago
NewAmsterdam Pharma Schedules R&D Day for June 2025
PremiumCompany AnnouncementsNewAmsterdam Pharma Schedules R&D Day for June 2025
3M ago
NewAmsterdam Pharma initiated with a Buy at Stifel
Premium
The Fly
NewAmsterdam Pharma initiated with a Buy at Stifel
3M ago
Promising Alzheimer’s Drug Development Fuels Buy Rating for NewAmsterdam Pharma
Premium
Ratings
Promising Alzheimer’s Drug Development Fuels Buy Rating for NewAmsterdam Pharma
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100